The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Causes, clinical features and outcomes of drug-induced liver injury in hospitalized patients in a Chinese tertiary care hospital
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In rare instances, causality gradings were not reported35 or RUCAM was used for causality grading but the respective publication remained unquoted,26,34 even if the updated RUCAM was mentioned in the text.34”
From Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases (2020) · cites this paper as [26]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Starting as early as 2006 with an analysis from Hong Kong,18 an overall 21 reports of HILI cases were published which had been assessed for causality using RUCAM with results presented by groups with first authors having their working place in mainland China, Hong Kong, or Taiwan.18–38”
From Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases (2020) · cites this paper as [26]
In the citing paper
“but few combined results of both HILI and DILI cases, causing confusion due to mixed data.24,26,30,36”
From Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases (2020) · cites this paper as [26]
In the citing paper
“In a few instances, publications erroneously mention in their title specifically only DILI, although HILI cases are also presented in the text,24,26,36”
From Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases (2020) · cites this paper as [26]
In the citing paper
“On top among the Asian countries is currently China, best explained by the large population and heavy use of herbal traditional Chinese medicines (TCMs), with increasing numbers of publications and cases until 2019.18–38”
From Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases (2020) · cites this paper as [26]
In the citing paper
“There is now increasing awareness of the benefits provided by RUCAM among various countries, including China,18–38 Korea,40–54 and Singapore,55,56 as evidenced by reports initially published in 2004 from Korea40 and in 2006 from China18 and Singapore,55 with subsequent articles (Table 1).”
From Herb-induced Liver Injury in Asia and Current Role of RUCAM for Causality Assessment in 11,160 Published Cases (2020) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martin, P., DiMartini, A., Feng, S., Brown, R., & Fallon, M. (2014) · Hepatology · doi:10.1002/hep.26972 · Cited by 1,045
Björnsson, E. S., Bergmann, O. M., Björnsson, H. K., Kvaran, R. B., & Olafsson, S. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.006 · Cited by 865
Flagged first, then by citations
Research works printed but not linked: 19
- Andrade RJ, Lucena MI, Fernandez MC, Pelaez G, Pachkoria K, Garcia-Ruiz E et al (2005) Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129:512–521 · DOI · Paper page
- Björnsson E, Olsson R (2005) Outcome and prognostic markers in severe drug-induced liver disease. Hepatology 42(2):481–489 · DOI · Paper page
- Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J et al (2008) Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 135:1924–1934 · DOI · Paper page
- Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ (2014) Practice Parameters Committee of the American College of Gastroenterology. ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol 109(7):950–966 · DOI · Paper page
- Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J et al (2015) United States drug induced liver injury network. features and outcomes of 889 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology 148(7):1340–1352 · DOI · Paper page
- Devarbhavi H, Dierkhising R, Kremers WK, Sandeep MS, Karanth D, Adarsh CK (2010) Single-center experience with drug induced liver injury from India: causes, outcome, prognosis, and predictors of mortality. Am J Gastroenterol 105:2396–2404 · DOI · Paper page
- Devarbhavi H, Singh R, Patil M et al (2013) Outcome and determinants of mortality in 269 patients with combination anti-tuberculosis drug-induced liver injury. J Gastroenterol Hepatol 28(1):161–167 · DOI · Paper page
- Jeong R, Lee YS, Sohn C, Jeon J, Ahn S, Lim KS (2015) Model for end-stage liver disease score as a predictor of short-term outcome in patients with drug-induced liver injury. Scand J Gastroenterol 50(4):439–446 · DOI
- Lai RT, Wang H, Gui HL, Ye MZ, Dai WJ, Xiang XG et al (2012) Clinical and pathological features in 138 cases of drug-induced liver injury. Zhonghua Gan Zang Bing Za Zhi 20(3):185–189. doi: 10.3760/cma.j.issn.1007-3418.2012.03.009 Article in Chinese · DOI
- Larrey D, Pageaux GP (2005) Drug-induced acute liver failure. Eur J Gastroenterol Hepatol 17(2):141–143 · DOI
- Lee WM (2003) Acute liver failure in the United States. Semin Liver Dis 23(3):217–226 · DOI
- Ostapowicz G, Fontana RJ, Schiødt FV, Larson A, Davern TJ, Han SH et al (2002) Results of a preospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137(12):947–954 · DOI · Paper page
- Polson J, Lee WM (2005) American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology 41(5):1179–1197 · DOI
- Said A, Williams J, Holden J, Remington P, Gangnon R, Musat A et al (2004) Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. J Hepatol 40(6):897–903 · DOI
- Shu CC, Lee CH, Lee MC, Wang JY, Yu CJ, Lee LN (2013) Hepatotoxicity due to first-line anti-tuberculosis drugs: a five-year experience in a Taiwan medical centre. Int J Tuberc Lung Dis 17(7):934–939. doi: 10.5588/ijtld.12.0782 · DOI
- Suk KT, Kim DJ, Kim CH, Park SH, Yoon JH, Kim YS et al (2012) A prospective nationwide study of drug induced liver injury in Korea. Am J Gastroenterol 107:1380–1387 · DOI · Paper page
- Temple R (2006) Hy’s law: predicting serious hepatotoxicity. Pharmacoepidemiol Drug Saf 15:241–243 · DOI
- Wai CT (2006) Presentation of drug-induced liver injury in Singapore. Singapore Med J 47:116–120
- Zhou Y, Yang L, Liao Z, He X, Zhou Y, Guo H (2013) Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21,789 patients. Eur J Gastroenterol Hepatol 25(7):825–829 · DOI · Paper page
Cited by
Sorted by citations
Drug induced liver injury – a 2023 update
Allison, R., Guraka, A., Shawa, I. T., Tripathi, G., Moritz, W., & Kermanizadeh, A. (2023) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2023.2261848 · Cited by 167
Teschke, R., Zhu, Y., & Jing, J. (2020) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00009 · Cited by 41
Metadata
- Authors
- Ou, P., Chen, Y., Li, B., Zhang, M., Liu, X., Li, F., Li, Y., Chen, C., Mao, Y., & Chen, J.
- Venue
- SpringerPlus
- Published
- 2015-12
- Volume
- 4
- Issue
- 1
- ISSN
- 2193-1801
- PMC
- PMC4688287
- Cited by
- 28
- References
- 2
- Language
- en
- Funders
- Ministry of Science and Technology of the People's Republic of China (2012ZX09303-001)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
